{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:01:26Z","timestamp":1694631686460},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1007\/s11864-001-0036-2","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T20:43:58Z","timestamp":1183581838000},"page":"225-235","source":"Crossref","is-referenced-by-count":0,"title":["T-small cell disorders"],"prefix":"10.1007","volume":"2","author":[{"given":"Eric H.","family":"Westin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan L.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"36_CR1","first-page":"286","volume":"30","author":"CS Rabkin","year":"1993","unstructured":"Rabkin CS, Devesa SS, Zahm SH, et al.: Increasing incidence of non-Hodgkin\u2019s lymphoma. Semin Hematol 1993, 30:286\u2013296.","journal-title":"Semin Hematol"},{"key":"36_CR2","first-page":"5496s","volume":"52","author":"N Pearce","year":"1992","unstructured":"Pearce N, Bethwaite P: Increasing incidence of non-Hodgkin\u2019s lymphoma: occupational and environmental factors. Cancer Res 1992, 52:5496s-5500s.","journal-title":"Cancer Res"},{"key":"36_CR3","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","volume":"49","author":"National Cancer Institute","year":"1982","unstructured":"National Cancer Institute: Sponsored study of classifications of non-Hodgkin\u2019s lymphomas. Summary and description of a working formulation for clinical usage. The Non-Hodgkin\u2019s Lymphoma Pathologic Classification Project. Cancer 1982, 49:2112\u20132135.","journal-title":"Cancer"},{"key":"36_CR4","first-page":"29","volume":"31","author":"K Lennert","year":"1975","unstructured":"Lennert K, Stein H, Kaiserling E: Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer 1975, 31(suppl):29\u201343.","journal-title":"Br J Cancer"},{"key":"36_CR5","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, et al.: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84:1361\u20131392.","journal-title":"Blood"},{"key":"36_CR6","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1023\/A:1008375931236","volume":"10","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, et al.: The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999, 10:1419\u20131432. This work summarizes the current classification scheme for all neoplastic diseases of hematopoietic and lymphoid origin, including the T-small cell disorders.","journal-title":"Ann Oncol"},{"key":"36_CR7","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1023\/A:1008462124002","volume":"9","author":"ES Jaffe","year":"1998","unstructured":"Jaffe ES, Harris NL, Diebold J, et al.: World Health Organization Classification of lymphomas: a work in progress. Ann Oncol 1998, 9(suppl):S25-S30.","journal-title":"Ann Oncol"},{"key":"36_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503\u2013511.","journal-title":"Nature"},{"key":"36_CR9","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood.V78.12.3269.3269","volume":"78","author":"E Matutes","year":"1991","unstructured":"Matutes E, Brito-Babapulle V, Swansbury J, et al.:Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991, 78:3269\u20133274.","journal-title":"Blood"},{"key":"36_CR10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.1986.tb07579.x","volume":"64","author":"E Matutes","year":"1986","unstructured":"Matutes E, Garcia M, Talavera J, et al.: The morphological spectrum of T-prolymphocytic leukaemia. Br J Haematol 1986, 64:111\u2013124.","journal-title":"Br J Haematol"},{"key":"36_CR11","first-page":"37","volume":"37","author":"MB van\u2019t Veer","year":"1990","unstructured":"van\u2019t Veer MB: Chromosome 14: a breakpoint in non-Hodgkin\u2019s lymphomas. Neth J Med 1990, 37:37\u201343.","journal-title":"Neth J Med"},{"key":"36_CR12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.V92.2.368","volume":"92","author":"C Gritti","year":"1998","unstructured":"Gritti C, Dastot H, Soulier J, et al.: Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. Blood 1998, 92:368\u2013373.","journal-title":"Blood"},{"key":"36_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0145-2126(98)80013-1","volume":"12","author":"A Butturini","year":"1988","unstructured":"Butturini A, Gale RP: Oncogenes in chronic lymphocytic leukemia. Leuk Res 1988, 12:89\u201392.","journal-title":"Leuk Res"},{"key":"36_CR14","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/jnci\/85.8.658","volume":"85","author":"H Dohner","year":"1993","unstructured":"Dohner H, Ho AD, Thaler J, et al.: Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group. J Natl Cancer Inst 1993, 85:658\u2013662. One of the largest studies reporting treatment of prolymphocytic leukemias with pentostatin.","journal-title":"J Natl Cancer Inst"},{"key":"36_CR15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1200\/JCO.1995.13.5.1284","volume":"13","author":"L Palomera","year":"1995","unstructured":"Palomera L, Domingo JM, Agullo JA, et al.: Complete remission in T-cell prolymphocytic leukemia with 2-chlorodeoxyadenosine. J Clin Oncol 1995, 13:1284\u20131285. This is not only a report of a treatment study, it is an excellent review of the use of purine analogs in T-cell prolymphocytic leukemia.","journal-title":"J Clin Oncol"},{"key":"36_CR16","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/eji.1830181217","volume":"18","author":"G Dighiero","year":"1988","unstructured":"Dighiero G, Lim A, Lembezat MP, et al.: Comparative study of VH gene family usage by newborn xid and non-xid mice, newborn NZB and adult NZB mice, and by splenic and peritoneal cavity B cell compartments. Eur J Immunol 1988, 18:1979\u20131983.","journal-title":"Eur J Immunol"},{"key":"36_CR17","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1200\/JCO.1997.15.7.2667","volume":"15","author":"R Pawson","year":"1997","unstructured":"Pawson R, Dyer MJ, Barge R, et al.: Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. J Clin Oncol 1997, 15:2667\u20132672.","journal-title":"J Clin Oncol"},{"key":"36_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1046\/j.1365-2141.1997.3213138.x","volume":"98","author":"A Bazarbachi","year":"1997","unstructured":"Bazarbachi A, Soriano V, Pawson R, et al.: Mycosis fungoides and S\u00e9zary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol 1997, 98:927\u2013933.","journal-title":"Br J Haematol"},{"key":"36_CR19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V89.1.256","volume":"89","author":"G Semenzato","year":"1997","unstructured":"Semenzato G, Zambello R, Starkebaum G, et al.:The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997, 89:256\u2013260.","journal-title":"Blood"},{"key":"36_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211","volume":"82","author":"TP Jr Loughran","year":"1993","unstructured":"Loughran TP Jr: Clonal diseases of large granular lymphocytes. Blood 1993, 82:1\u201314.","journal-title":"Blood"},{"key":"36_CR21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0025-6196(12)61377-9","volume":"69","author":"MV Dhodapkar","year":"1994","unstructured":"Dhodapkar MV, Lust JA, Phyliky RL: T-cell large granular lymphocytic leukemia and pure red cell aplasia in a patient with type I autoimmune polyendocrinopathy: response to immunosuppressive therapy. Mayo Clin Proc 1994, 69:1085\u20131088.","journal-title":"Mayo Clin Proc"},{"key":"36_CR22","first-page":"S46","volume":"11","author":"D Kingreen","year":"1997","unstructured":"Kingreen D, Siegert W: Chronic lymphatic leukemias of T and NK cell type. Leukemia 1997, 11(suppl):S46-S49.","journal-title":"Leukemia"},{"key":"36_CR23","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood.V84.5.1620.1620","volume":"84","author":"MV Dhodapkar","year":"1994","unstructured":"Dhodapkar MV, Li CY, Lust JA, et al.: Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994, 84:1620\u20131627.","journal-title":"Blood"},{"key":"36_CR24","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood.V84.7.2164.2164","volume":"84","author":"TP Jr Loughran","year":"1994","unstructured":"Loughran TP Jr, Kidd PG, Starkebaum G: Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 1994, 84:2164\u20132170.","journal-title":"Blood"},{"key":"36_CR25","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1182\/blood.V91.9.3372","volume":"91","author":"R Sood","year":"1998","unstructured":"Sood R, Stewart CC, Aplan PD, et al.: Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 1998, 91:3372\u20133378.","journal-title":"Blood"},{"key":"36_CR26","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood.V88.8.3245.bloodjournal8883245","volume":"88","author":"A Tefferi","year":"1996","unstructured":"Tefferi A, Lacy MQ, Kurtin PJ: Response: pure red blood cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 1996, 88:3245\u20133246.","journal-title":"Blood"},{"key":"36_CR27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000418084","volume":"19","author":"RC Beljaards","year":"1990","unstructured":"Beljaards RC, Meijer CJ, Scheffer E, et al.: Cutaneous large cell lymphomas of T cell origin: diagnosis, classification and prognostic parameters. Curr Probl Dermatol 1990, 19:144\u2013149.","journal-title":"Curr Probl Dermatol"},{"key":"36_CR28","first-page":"276","volume":"26","author":"YH Kim","year":"1999","unstructured":"Kim YH, Hoppe RT: Mycosis fungoides and the S\u00e9zary syndrome. Semin Oncol 1999, 26:276\u2013289.","journal-title":"Semin Oncol"},{"key":"36_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1067\/mjd.2000.110071","volume":"43","author":"HS Zackheim","year":"2000","unstructured":"Zackheim HS, Vonderheid EC, Ramsay DL, et al.: Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol 2000, 43:793\u2013796.","journal-title":"J Am Acad Dermatol"},{"key":"36_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000018423","volume":"201","author":"Suarez-Varela MM Morales","year":"2000","unstructured":"Morales Suarez-Varela MM, Llopis GA, Marquina VA, et al.: Mycosis fungoides: review of epidemiological observations. Dermatology 2000, 201:21\u201328.","journal-title":"Dermatology"},{"key":"36_CR31","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","volume":"88","author":"E Diamandidou","year":"1996","unstructured":"Diamandidou E, Cohen PR, Kurzrock R: Mycosis fungoides and S\u00e9zary syndrome. Blood 1996, 88:2385\u20132409.","journal-title":"Blood"},{"key":"36_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00000478-200001000-00005","volume":"24","author":"M Santucci","year":"2000","unstructured":"Santucci M, Biggeri A, Feller AC, et al.: Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol 2000, 24:40\u201350. This is one of the largest cooperative reviews of efficacy of criteria used in the diagnosis of mycosis fungoides.","journal-title":"Am J Surg Pathol"},{"key":"36_CR33","first-page":"978","volume":"11","author":"KF Izban","year":"1998","unstructured":"Izban KF, Hsi ED, Alkan S: Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections. Mod Pathol 1998, 11:978\u2013982.","journal-title":"Mod Pathol"},{"key":"36_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1085-5629(00)80005-X","volume":"19","author":"MS Howard","year":"2000","unstructured":"Howard MS, Smoller BR: Mycosis fungoides: classic disease and variant presentations. Semin Cutan Med Surg 2000, 19:91\u201399.","journal-title":"Semin Cutan Med Surg"},{"key":"36_CR35","first-page":"276","volume":"26","author":"YH Kim","year":"1999","unstructured":"Kim YH, Hoppe RT: Mycosis fungoides and the S\u00e9zary syndrome. Semin Oncol 1999, 26:276\u2013289.","journal-title":"Semin Oncol"},{"key":"36_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1001\/archderm.134.2.158","volume":"134","author":"DE Kern","year":"1998","unstructured":"Kern DE, Kidd PG, Moe R, et al.: Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications. Arch Dermatol 1998, 134:158\u2013164.","journal-title":"Arch Dermatol"},{"key":"36_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF00412557","volume":"276","author":"SC Van der Putte","year":"1984","unstructured":"Van der Putte SC, Toonstra J, van Prooyen HC, et al.:S\u00e9zary syndrome with early immunoblastic transformation. Arch Dermatol Res 1984, 276:17\u201326.","journal-title":"Arch Dermatol Res"},{"key":"36_CR38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1200\/JCO.1987.5.2.208","volume":"5","author":"E Dmitrovsky","year":"1987","unstructured":"Dmitrovsky E, Matthews MJ, Bunn PA, et al.: Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis. J Clin Oncol 1987, 5:208\u2013215.","journal-title":"J Clin Oncol"},{"key":"36_CR39","first-page":"265","volume":"132","author":"KE Salhany","year":"1988","unstructured":"Salhany KE, Cousar JB, Greer JP, et al.: Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. Am J Pathol 1988, 132:265\u2013277.","journal-title":"Am J Pathol"},{"key":"36_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00000478-199206000-00002","volume":"16","author":"L Cerroni","year":"1992","unstructured":"Cerroni L, Rieger E, Hodl S, et al.: Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma. Am J Surg Pathol 1992, 16:543\u2013552.","journal-title":"Am J Surg Pathol"},{"key":"36_CR41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/10428199509059655","volume":"18","author":"E Matutes","year":"1995","unstructured":"Matutes E, Schulz T, Dyer M, et al.: Immunoblastic transformation of a S\u00e9zary syndrome in a black Caribbean patient without evidence of HTLV-I. Leuk Lymph 1995, 18:521\u2013527.","journal-title":"Leuk Lymph"},{"key":"36_CR42","first-page":"2212","volume":"95","author":"B Vergier","year":"2000","unstructured":"Vergier B, de Muret A, Beylot-Barry M, et al.: Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas. Blood 2000, 95:2212\u20132218.","journal-title":"Blood"},{"key":"36_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/canjclin.43.2.93","volume":"43","author":"EA Abel","year":"1993","unstructured":"Abel EA, Wood GS, Hoppe RT: Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatment. CA Cancer J Clin 1993, 43:93\u2013115.","journal-title":"CA Cancer J Clin"},{"key":"36_CR44","first-page":"293","volume":"14","author":"RT Hoppe","year":"1990","unstructured":"Hoppe RT, Wood GS, Abel EA: Mycosis fungoides and the S\u00e9zary syndrome: pathology, staging, and treatment. Curr Probl Cancer 1990, 14:293\u2013371.","journal-title":"Curr Probl Cancer"},{"key":"36_CR45","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0889-8588(18)30058-3","volume":"9","author":"GW Jones","year":"1995","unstructured":"Jones GW, Hoppe RT, Glatstein E: Electron beam treatment for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995, 9:1057\u20131076.","journal-title":"Hematol Oncol Clin North Am"},{"key":"36_CR46","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1001\/archderm.132.11.1309","volume":"132","author":"YH Kim","year":"1996","unstructured":"Kim YH, Jensen RA, Watanabe GL, et al.: Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 1996, 132:1309\u20131313. This is a critical review of long-term experience in the treatment of limited stage mycosis fungoides with a variety of treatment modalities.","journal-title":"Arch Dermatol"},{"key":"36_CR47","first-page":"1545","volume":"138","author":"GS Wood","year":"1991","unstructured":"Wood GS, Dubiel C, Mueller C, et al.: Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA. Am J Pathol 1991, 138:1545\u20131552.","journal-title":"Am J Pathol"},{"key":"36_CR48","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/archderm.129.6.747","volume":"129","author":"EN Mostow","year":"1993","unstructured":"Mostow EN, Neckel SL, Oberhelman L, et al.: Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA. Arch Dermatol 1993, 129:747\u2013752.","journal-title":"Arch Dermatol"},{"key":"36_CR49","first-page":"809","volume":"84","author":"S Rupoli","year":"1999","unstructured":"Rupoli S, Barulli S, Guiducci B, et al.: Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group. Haematologica 1999, 84:809\u2013813.","journal-title":"Haematologica"},{"key":"36_CR50","first-page":"1197","volume":"7","author":"U Wollina","year":"2000","unstructured":"Wollina U, Liebold K, Kaatz M, et al.: Survival of patients with cutaneous T-cell lymphoma after treatment with extracorporeal photochemotherapy. Oncol Rep 2000, 7:1197\u20131201.","journal-title":"Oncol Rep"},{"key":"36_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0190-9622(98)70403-7","volume":"39","author":"MN Saleh","year":"1998","unstructured":"Saleh MN, LeMaistre CF, Kuzel TM, et al.: Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides. J Am Acad Dermatol 1998, 39:63\u201373. This is an important study detailing current use of deneleukin diftitox in mycosis fungoides.","journal-title":"J Am Acad Dermatol"},{"key":"36_CR52","first-page":"399","volume":"91","author":"CF LeMaistre","year":"1998","unstructured":"LeMaistre CF, Saleh MN, Kuzel TM, et al.: Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2. Blood 1998, 91:399\u2013405. This is a second critical study detailing the use of deneleukin diftitox in mycosis fungoides.","journal-title":"Blood"},{"key":"36_CR53","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V84.6.1765.1765","volume":"84","author":"FM Foss","year":"1994","unstructured":"Foss FM, Borkowski TA, Gilliom M, et al.: Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the S\u00e9zary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II study. Blood 1994, 84:1765\u20131774.","journal-title":"Blood"},{"key":"36_CR54","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3816\/CLM.2000.s.009","volume":"1","author":"P Heald","year":"2000","unstructured":"Heald P: The treatment of cutaneous T-cell lymphoma with a novel retinoid. Clin Lymphoma 2000, 1:545\u2013549.","journal-title":"Clin Lymphoma"},{"key":"36_CR55","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1200\/JCO.1994.12.10.2051","volume":"12","author":"FM Foss","year":"1994","unstructured":"Foss FM, Ihde DC, Linnoila IR, et al.: Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides\/S\u00e9zary syndrome. J Clin Oncol 1994, 12:2051\u20132059.","journal-title":"J Clin Oncol"},{"key":"36_CR56","first-page":"647","volume":"63","author":"PN Grozea","year":"1979","unstructured":"Grozea PN, Jones SE, McKelvey EM, et al.: Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study. Cancer Treat Rep 1979, 63:647\u2013653.","journal-title":"Cancer Treat Rep"},{"key":"36_CR57","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","volume":"321","author":"FJ Kaye","year":"1989","unstructured":"Kaye FJ, Bunn PA, Steinberg SM, et al.: A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989, 321:1784\u20131790.","journal-title":"N Engl J Med"},{"key":"36_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hon.2900060103","volume":"6","author":"C Shustik","year":"1988","unstructured":"Shustik C, Mick R, Silver R, et al.: Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation. Hematol Oncol 1988, 6:7\u201312.","journal-title":"Hematol Oncol"},{"key":"36_CR59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000429580","volume":"25","author":"RT Hoppe","year":"1991","unstructured":"Hoppe RT: Total skin electron beam therapy in the management of mycosis fungoides. Front Radiat Ther Oncol 1991, 25:80\u201389.","journal-title":"Front Radiat Ther Oncol"},{"key":"36_CR60","first-page":"46","volume":"5","author":"RT Hoppe","year":"1991","unstructured":"Hoppe RT: The management of mycosis fungoides at Stanford\u2014standard and innovative treatment programmes. Leukemia 1991, 5(suppl):46\u201348.","journal-title":"Leukemia"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0036-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-001-0036-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0036-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0036-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T14:21:14Z","timestamp":1652624474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-001-0036-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1007\/s11864-001-0036-2","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}